Debt-to-equity of TG THERAPEUTICS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TG THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • TG THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 121%, a 17% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TG THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 121% -24% -17% 30 Sep 2025
Q2 2025 172% +55% +47% 30 Jun 2025
Q1 2025 168% +29% +21% 31 Mar 2025
Q4 2024 158% -17% -9.6% 31 Dec 2024
Q3 2024 145% -79% -35% 30 Sep 2024
Q2 2024 116% -149% -56% 30 Jun 2024
Q1 2024 139% -34% -20% 31 Mar 2024
Q4 2023 174% +64% +58% 31 Dec 2023
Q3 2023 224% +143% +177% 30 Sep 2023
Q2 2023 266% 30 Jun 2023
Q1 2023 173% 31 Mar 2023
Q4 2022 111% 31 Dec 2022
Q3 2022 81% 30 Sep 2022
Q4 2012 56% 31 Dec 2012
Q3 2012 60% 30 Sep 2012
Q2 2012 112% 30 Jun 2012
Q1 2012 262% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.